1. Home
  2. MLYS vs NTGR Comparison

MLYS vs NTGR Comparison

Compare MLYS & NTGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • NTGR
  • Stock Information
  • Founded
  • MLYS 2019
  • NTGR 1996
  • Country
  • MLYS United States
  • NTGR United States
  • Employees
  • MLYS N/A
  • NTGR N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • NTGR Telecommunications Equipment
  • Sector
  • MLYS Health Care
  • NTGR Utilities
  • Exchange
  • MLYS Nasdaq
  • NTGR Nasdaq
  • Market Cap
  • MLYS 890.6M
  • NTGR 820.0M
  • IPO Year
  • MLYS 2023
  • NTGR N/A
  • Fundamental
  • Price
  • MLYS $14.89
  • NTGR $27.48
  • Analyst Decision
  • MLYS Strong Buy
  • NTGR Strong Buy
  • Analyst Count
  • MLYS 4
  • NTGR 2
  • Target Price
  • MLYS $27.00
  • NTGR $32.00
  • AVG Volume (30 Days)
  • MLYS 869.6K
  • NTGR 582.4K
  • Earning Date
  • MLYS 08-12-2025
  • NTGR 07-30-2025
  • Dividend Yield
  • MLYS N/A
  • NTGR N/A
  • EPS Growth
  • MLYS N/A
  • NTGR N/A
  • EPS
  • MLYS N/A
  • NTGR 2.16
  • Revenue
  • MLYS N/A
  • NTGR $697,865,000.00
  • Revenue This Year
  • MLYS N/A
  • NTGR $4.83
  • Revenue Next Year
  • MLYS N/A
  • NTGR $3.86
  • P/E Ratio
  • MLYS N/A
  • NTGR $12.73
  • Revenue Growth
  • MLYS N/A
  • NTGR 0.41
  • 52 Week Low
  • MLYS $8.24
  • NTGR $15.35
  • 52 Week High
  • MLYS $18.38
  • NTGR $31.55
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 55.68
  • NTGR 61.61
  • Support Level
  • MLYS $14.26
  • NTGR $24.40
  • Resistance Level
  • MLYS $15.55
  • NTGR $25.14
  • Average True Range (ATR)
  • MLYS 0.85
  • NTGR 0.95
  • MACD
  • MLYS 0.18
  • NTGR 0.34
  • Stochastic Oscillator
  • MLYS 77.53
  • NTGR 78.38

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

About NTGR NETGEAR Inc.

Netgear Inc provider of networking technologies for businesses, homes, and service providers. It delivers a wide range of intelligent solutions designed to unleash the full potential of connectivity. The group has two segments: NETGEAR for Business and Connected Home which offers reliable, easy-to-use, high-performance networking solutions, including switches, routers, access points, software, and AV over IP technologies, tailored to meet the diverse needs of organizations of all sizes. The Connected Home segment offers connectivity, powerful performance, and enhanced security features right out of the box, designed to help keep families safe online, and Others. It conduct business across three geographic territories: Americas; Europe, Middle East and Africa; and Asia Pacific.

Share on Social Networks: